shutterstock_1739736104_Feb 8 2021_grayscale_2.jpg
1/4

Visionary Healthcare Investors

BioStar Capital is making a difference in patients' lives with uncompromising fund performance.

          >> LEARN ABOUT OUR STRATEGY

          

Picture5.png
Medical Team 2.png

Business Acumen Meets

Clinical Expertise

The BioStar team represents a unique collaboration between experienced investment professionals and clinicians with global reputations as medical thought leaders.

                                                                                >> MEET THE TEAM

Innovations with an Impact

For over 17 years, BioStar Capital has been at the forefront of transformational medical technology through partnerships with innovative companies.

                                                                                                               >> VIEW OUR PORTFOLIO

Portfolio News

September 29, 2021

TransMedics Receives FDA Approval for its OCS Liver System for Preservation and Assessment of Donor Livers for Transplantation

    >> Read More

September 7, 2021

TransMedics Receives FDA Approval for its OCS Heart System Enabling Broader Utilization of Donor Hearts for Transplantation in the U.S.­

    >> Read More

BioStar News

May 25, 2021

Jeffrey Yau, PhD, VP of Data Science and Engineering at Walmart Global Technology, Joins BioStar Capital as Entrepreneur in Residence

    >> Read More

January 15, 2021

DeviceTalks Weekly features Mark Toland, BioStar Entrepreneur-in-Residence: Digging into the Digital Medtech & Surgical Worlds

    >> Read More